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The genomewide screen to search for asthma-susceptibility loci, in the Collaborative Study on the Genetics of
Asthma (CSGA), has been conducted in two stages and includes 266 families (199 nuclear and 67 extended pedigrees)
from three U.S. populations: African American, European American, and Hispanic. Evidence for linkage with the
asthma phenotype was observed for multiple chromosomal regions, through use of several analytical approaches
that facilitated the identification of multiple disease loci. Ethnicity-specific analyses, which allowed for different
frequencies of asthma-susceptibility genes in each ethnic population, provided the strongest evidence for linkage at
6p21 in the European American population, at 11q21 in the African American population, and at 1p32 in the
Hispanic population. Both the conditional analysis and the affected-sib-pair two-locus analysis provided further
evidence for linkage, at 5q31, 8p23, 12q22, and 15q13. Several of these regions have been observed in other
genomewide screens and linkage or association studies, for asthma and related phenotypes. These results were used
to develop a conceptual model to delineate asthma-susceptibility loci and their genetic interactions, which provides
a promising basis for initiation of fine-mapping studies and, ultimately, for gene identification.
Introduction
Asthma (MIM 600807) is a common respiratory disease
characterized by variable airflow obstruction, inflam-
mation of the airways, and bronchial hyperresponsive-
ness (BHR). Although family studies, twin studies, adop-
tion studies, and segregation analyses have provided
evidence for a genetic component in the etiology of
asthma, the mode of inheritance is complex and not yet
fully understood (Ober and Moffatt 2000). It is likely
that several genes, each with moderate-to-major effects,
act together with environmental exposures to determine
an individual’s overall risk of development of asthma.
Genetic analytic techniques that permit simultaneous
consideration of susceptibility genes in multiple chro-
mosomal regions may enhance the mapping of genes
controlling risk to common multigenic diseases. Con-
ditional analysis incorporates linkage evidence from one
chromosomal region while assessing evidence for link-
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age at a second region (or multiple regions), by weight-
ing families according to their evidence for linkage at
the first region (Kong and Cox 1997; Cox et al. 1999).
A two-locus identity-by-descent (IBD) method, which
simultaneously evaluates IBD sharing at two unlinked
marker loci, represents a similar approach (Cordell et
al. 1995, 2000). When two genes influence an individ-
ual’s susceptibility to a disease, affected sib pairs may
show a predictable relationship in their IBD scores, al-
though quite different genetic models can generate sim-
ilar profiles of IBD sharing. Once reproducible evidence
for interaction has been identified, the likelihood that
the regions actually contain susceptibility loci is in-
creased.
The Collaborative Study on the Genetics of Asthma
(CSGA) is a multicenter collaborative study supported
by the National Heart, Lung and Blood Institute of the
NIH (NHLBI/NIH), whose purpose is to identify im-
portant loci that contribute to the development of
asthma and asthma-associated phenotypes. We have
previously reported the results of an initial genomewide
screen of the first 140 families (CSGA 1997) and have
now collected and genotyped more individuals in the
first 140 families as well as in 126 new families. All 266
families were ascertained through sib pairs with asthma
at the CSGA centers in the United States. Three hundred
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twenty-three polymorphic markers, evenly distributed
across the genome, were genotyped in the 266 families.
Because it is possible that different genes, as well as
environmental exposures, influence asthma and asthma-
associated phenotypes in individuals of different ethnic
backgrounds, three ethnic groups (African Americans,
European Americans, and Hispanics) were ascertained
in this study.
We report here the results of a systematic genomewide
search for asthma-susceptibility genes in the total sam-
ple and in each of the three ethnic groups, using mul-
tipoint analyses based on allele sharing among affected
relatives, to determine evidence for linkage. In addition,
we conducted a systematic search for gene-gene inter-
actions, using conditional analysis and the affected-sib-
pair two-locus approach. Conditional linkage analysis
was performed for the four regions identified in the
initial genomewide screen (one region from the entire
population and one from each of the three ethnic
groups), by assignment of weights to families, on the
basis of their nonparametric linkage (NPL) scores at
these loci. In the affected-sib-pair two-locus analysis,
the observed joint IBD sharing for two marker loci
among affected siblings was maximized over several
two-locus models. LOD scores were calculated by com-
paring the likelihood of the observed IBD to that ex-
pected under the null hypothesis of no linkage. On the
basis of these analyses, we propose a model for loci
contributing to asthma susceptibility and for their po-
tential interactions.
Subjects and Methods
Family Ascertainment
The ascertainment scheme has been reported in detail
elsewhere (CSGA 1997). In brief, families were ascer-
tained at the four CSGA centers: (1) Johns Hopkins Uni-
versity (Baltimore), with additional recruitment of fam-
ilies at Howard University (Washington, D.C.); (2) The
University of Chicago; (3) the University of Minnesota;
and (4) the University of Maryland, with additional re-
cruitment of families at the University of New Mexico.
Families were ascertained through two siblings with
asthma and then were expanded to include other affected
relatives, by extending the family either through relatives
with asthma or through one unaffected relative. The
siblings with asthma in each family met the following
criteria: (1) age 6 years; (2) either (a) bronchial hy-
perresponsiveness, defined by a fall in baseline forced
expiratory volume at one second (FEV1) 20% at 25
mg/ml methacholine or (b) bronchodilator reversibility,
defined as a 15% increase in baseline FEV1 after in-
halation of a bronchodilator (albuterol), in subjects
whose FEV1 was reduced; (3) at least two symptoms
(cough, wheeze, and dyspnea) consistent with asthma;
(4) fewer than three pack years of cigarette exposure;
and (5) physician’s diagnosis of asthma and no conflict-
ing pulmonary diagnoses.
All subjects were evaluated by standardized protocols.
Baseline spirometry was performed according to Amer-
ican Thoracic Society (ATS) criteria (ATS 1991, 1995).
Methacholine was administrated in doubling concentra-
tions (0.15 mg/ml to 10.0 mg/ml, then 25 mg/ml) at 5-
min intervals, inhaled through a DeVilbiss #646 neb-
ulizer attached to a solenoid trigger, activated on
inspiration for 0.6 s, for each of five breaths (Chai et
al. 1975; Chatham et al. 1982). The PC20 FEV1 was
defined as the concentration of methacholine that results
in a 20% fall in FEV1. Subjects with a PC20 FEV1 25
mg/ml methacholine were considered to demonstrate
BHR. Airway reversibility to a b2 agonist was assessed
by administration of albuterol by either a metered dose
inhaler or a hand-held nebulizer. Spirometry was re-
peated 15 min after this treatment.
The standard ATS respiratory questionnaire wasmod-
ified to include questions about the frequency, severity,
and duration of symptoms of both asthma and atopy,
to identify conflicting diagnoses, and to assess current
and prior asthma therapy. Relatives of probands were
classified as having asthma if they reported a past or
current history of at least two of the three respiratory
symptoms (cough, wheeze, or dyspnea), had a physi-
cian’s diagnosis of asthma, and demonstrated either
BHR or bronchodilator reversibility.
Genotyping
DNA was extracted from whole blood, by standard
methods, at each of the four centers and was sent to the
Mammalian Genotyping Service in Marshfield, WI, for
genotyping. DNA samples were genotyped for 323 poly-
morphic autosomal markers. The order of and distances
between the markers were estimated by CRIMAP (∼5%
of these markers were genotyped at individual CSGA
centers) (Lander and Green 1987). The resulting maps
were consistent with the Marshfield map, and there was
no region in which the intermarker distance was 120
cM.
Analytical Methods
Estimates of allele sharing were based on the marker-
allele frequencies estimated from the pedigree founders
for each ethnic group. However, the impact of marker-
allele frequencies on LOD scores was negligible in this
study because the parents were genotyped in themajority
of the families. Linkage results were very similar,
whether the marker-allele frequencies were estimated
from each ethnic group or from the overall sample.
Evidence for linkage over the entire genome was ob-
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Table 1
Clinical Characteristics of Family Members with Asthma
CLINICAL CHARACTERISTIC
MEAN  SD (n)
African American European American Hispanic
Age at exam (years) 1912 (350) 2415 (444) 1511 (91)
Age at first symptom (years) 78 (344) 910 (434) 55 (89)
Sex ratio (M:F) 168:18 206:23 50:4
FEV1 (% predicted)
a 8518 (350) 9017 (444) 9219 (91)
FEV1/forced vital capacity 8210 (350) 8010 (444) 7910 (91)
PC20 FEV1(mg/ml methacholine) 4.55.9 (252) 5.26.5 (394) 4.85.7 (79)
Bronchodilator reversibility (%) 2813.3 (97) 33.423.3 (50) 38.917.3 (11)
1 positive skin test (%) 7444 (345) 7742 (438) 9227 (91)
Mean log of immunoglobulin E (IgE) (IU/ml) 2.35.66 (346) 2.14.68 (439) 2.49.55 (86)
Geometric mean IgE concentration 225 (346) 139 (439) 306 (86)
a Because of physical differences in upper-body size, % predicted values are adjusted for age, sex, height,
and ethnicity, using the ATS Standards (ATS 1991, 1995). It is important to note that % predicted values are
given for comparison purposes only. Actual FEV1 measurements during the methacholine challenge were used
to determine whether a subject had bronchial hyperresponsiveness, one of the criteria for asthma.
tained by nonparametric multipoint linkage analysis, us-
ing the “S(all)” statistic of the computer programGENE-
HUNTER-PLUS (Kruglyak et al. 1996; Kong and Cox
1997). One-parameter allele-sharing–model LOD scores
were calculated based on the distribution of test statistics
under the null hypothesis and conditional on the data
using the ASM computer program (Kong and Cox
1997), for each population separately and for the three
populations combined. For the initial genomewide
screen, equal weights were assigned to each family. LOD
scores from this analysis can be converted to a x2 statistic
by multiplying by 4.6, which is approximately a x2
distribution with a mixture of degrees of freedom of 1
and 0, under the null hypothesis of no linkage (Fara-
way 1993). P values were calculated as .5# [1 (1
, where P1 is the P value of x
2 with 1 df.P )(1 P )]1 1
Conditional analyses were performed four times, by
conditioning on each of four regions identified in the
genomewide screen (the region with the highest LOD
score, from the total sample as well as from each of the
three ethnic populations) and then searching the rest of
the genome for evidence of additional loci. In the con-
ditional analyses, the weighting of each family was based
on their evidence for linkage at these regions. Two
weighting schemes were used to model a positive and a
negative relationship between loci on different chro-
mosomes. A positive relationship (gene-gene interaction)
was modeled by assigning a weight of 0 to families with
linkage scores that either equaled 0 or were negative and
a weight of 1 to families with linkage scores that were
positive (weight0-1). This positive relationship may be
due to various underlying biological models, such as a
multiplicative model or positive epistasis. A negative
relationship (heterogeneity gene-gene interaction) was
modeled by assigning a weight of 1 to families with
linkage scores that were negative and a weight of 0 to
families with linkage scores that either equaled 0 or were
positive (weight1-0).
The empirical significance of the LOD scores from the
conditional analyses was estimated from computer sim-
ulations. The original linkage score at a specific location
for each family was obtained by GENEHUNTER-PLUS,
on the basis of the actual data. A fixed proportion rep-
resenting the actual distribution of linkage scores, by
family, at the region that is being conditioned on was
used. Weights were then randomly assigned to each fam-
ily so that the number of families was the same as that
included in the actual analysis, and the LOD score was
then calculated. This procedure was repeated 5,000
times, and the empirical significance of the observed
LOD score was estimated as the proportion of the rep-
licates exceeding the observed conditional LOD score.
The two-locus analyses (joint analysis of two loci si-
multaneously) were performed by the computer program
TWOLOC (Farrell 1997), which uses the output from
the program VITESSE (O’Connell and Weeks 1995).
These analyses were limited to the markers that had
elevated LOD scores in the conditional analyses. The
joint probability of affected sib pairs sharing allele i IBD
at locus 1 and allele j IBD at locus 2 (zij) was maximized,
with the genetic restrictions taken into account, by a
quasi-Newtonian algorithm (Cordell et al. 1995). The
maximum LOD score (MLS) was then calculated by
comparing the maximum likelihood to the likelihood
under the null hypothesis of no involvement at either
locus. Three two-locus MLS values were calculated—for
the general, multiplicative, and heterogeneity models. In
the general two-locus model, zij varied freely within the
ranges that are genetically valid. In the multiplicative
and heterogeneity two-locus models, the maximization
procedure was restricted so that the joint IBD sharing
was allowed to vary only in a way consistent with the
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specific model. Relative values of LOD-score statistics
for different models can be used to identify that model
which best describes the relationship between the dif-
ferent loci. The general model will always fit at least as
well as any other model, since all other models are nested
within the general model. LOD scores under the mul-
tiplicative model equal the sum of the single-locus LOD
scores (Cordell et al. 1995).
Although, through use of asymptotic theory (Cox and
Hinkley 1974), it may be possible to calculate the dis-
tribution of the two-locus LOD score, it would be com-
plicated because of the nonstandard genetic restrictions
on this maximization procedure (Cordell et al. 1995).
Therefore, computer simulation was performed to eval-
uate the significance of the observed two-locus LOD
scores. Two independent markers were simulated as
being unlinked to a dominant disease locus in the 266
families, by means of FASTSLINK (Weeks et al. 1990;
Statgen Software Web site). The disease-gene frequency
was assumed to be .05, with penetrances of 90% and
1% for the gene carriers and gene noncarriers, respec-
tively. These parameters are consistent with a population
prevalence of 10% for asthma and a 10% phenocopy
rate. The exact pedigree structure and availability of
DNA samples in these CSGA families were used in this
simulation. The number of alleles for each marker, as
well as the marker-allele frequencies, also reflected the
actual markers genotyped. Five thousand replicates
were generated, and each replicate was analyzed by
TWOLOC (Farrell 1997). The proportion of the 5,000
replicates with a LOD score (under general, heteroge-
neity, and multiplicative models) exceeding the observed
values from analyses of the actual data was used as a
nominal P value.
Results
Family Characteristics
The clinical characteristics of all family members with
asthma, in each ethnic group, are listed in table 1. Our
sample represents the total number of families for whom
data has been collected by the CSGA and is a much
larger sample than that reported for the set of families
in the original study (CSGA 1997). There are no sig-
nificant differences, in these clinical characteristics, be-
tween the first and second set of families (data not
shown).
Genomewide Screen
The results of the genomewide screen in the 266 fam-
ilies are presented in figure 1. Multiple regions across
the genome showed some evidence for linkage in the
total sample, although no chromosomal region had a
LOD score 12.0. The highest LOD score was at 14q32
(LOD 1.23, ). Two other regions (5q31 andPp .017
12q22) had LOD scores 11.0, whereas seven other
regions (1p, 4q, 8p, 11q, 12p, 13q, and 17q) had LOD
scores 10.5.
Analyses were also performed separately for each eth-
nic group, to investigate genetic differences between the
groups. In the 107 African American families, evidence
for linkage was found at 11q21, with a LOD score of
2.00 ( ) at marker D11S1985, with no otherPp .002
regions having a LOD score 1. In the 129 European
American families, evidence for linkage was found at
6p21, with a LOD score of 1.91 ( ) at markerPp .003
D6S1281. LOD scores 1 were found at 8p23, with a
LOD score of 1.06 at marker D8S1130; at 19q13, with
a LOD score of 1.02 at marker D19S198; and on 20p13,
with a LOD score of 1.07 at marker D20S473. In the
30 Hispanic families, the highest LOD score over the
whole genome was found on 1p32, with a value of 2.92
( ) at marker D1S2134. Seven other regionsPp .0002
had LOD scores 11 (2q, 5q, 11p, 12q, 14q, 17q, and
21q).
Conditional Analysis
The results of the genomewide conditional analyses
in these 266 families are presented in figure 2. Condi-
tional analyses were performed by weighting the families
on the basis of the linkage results at four regions—1p32,
6p21, 11q21, and 14q32 (the regions with the strongest
evidence for linkage in each ethnic group and in the total
sample)—and under the assumption of a positive rela-
tionship between loci (i.e., weight0-1). LOD scores that
were significantly increased, compared with those in the
unconditional analysis, were observed at only four loci:
the LOD score at 5q31 (D5S1480) increased from 0.98
to 3.21 when conditioned on the evidence for linkage
results at 1p32 (D1S2134); the LOD score at 8p23
(D8S1130) increased from 0.87 to 2.90 when condi-
tioned on linkage results at 11q21 (D11S2002); the LOD
scores at 15q13 (D15S153) increased from 0.33 to 2.70
and 2.06, when conditioned on linkage results at 14q32
(D14S749) and 1p32 (D1S2134), respectively; and the
LOD scores at 12q22 (D12S2070) increased from 1.13
to 2.15 and 2.00, when conditioned on linkage results
at 14q32 (D14S749) and 11q21 (D11S2002), respec-
tively. A similar conditional analysis was performed un-
der the assumption of heterogeneity, but no LOD scores
significantly increased over the original results were ob-
served (data not shown).
Computer simulation was used to evaluate empirically
the significance of these increased LOD scores obtained
from this conditional analysis of the 266 families. The
increased LOD scores at four of these chromosomal
regions were statistically significant (table 2). In the
5,000 replicates of the conditional analyses, a LOD score
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Figure 1 Results of genomewide screen for asthma-susceptibility loci. Allele-sharing multipoint LOD scores are shown, and the marker
identification is given for LOD scores 11. Results for the total CSGA data set are shown in the top graph, followed by the results for each
ethnic group.
3.21 at 5q31 was observed only once, leading to an
empirical P value of .0002. Similarly, no conditional
LOD score 12.90 at 8p23 was observed among 5,000
replicates, which leads to an empirical P value !.0002.
Evidence for linkage at 15q13 was observed in condi-
tional analyses of both chromosomes 1p32 (Pp
) and 14q32 ( )..0016 P ! .0002
Two-Locus Analyses
Results of the affected-sib-pair two-locus IBD-sharing
analyses, as well as those of the single-locus IBD-sharing
analysis for the regions identified in the conditional anal-
yses, are presented in table 3. These results can be sum-
marized as follows:
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Figure 2 Results of conditional analyses for asthma-susceptibility loci, for the total CSGA data set. The genomewide conditional analysis
was performed four times, conditional on the evidence for linkage to each of the chromosomes 1, 6, 11, and 14. Allele-sharing multipoint LOD
scores are shown, and marker identification is given at the peak LOD-score values.
1. There was evidence for linkage in several chro-
mosomal regions when the interactive two-locus analysis
was used. Specifically, the two-locus LOD scorewas 3.23
( ) for markers D14S749 and D12S2070 andPp .001
2.88 ( ) for markers D11S2002 and D12S2070.Pp .003
The evidence for linkage at the second locus, conditional
on linkage at the first locus, is determined by the dif-
ference between the general and locus 1 LOD scores; for
example, the resulting LOD scores for chromosome 12,
conditional on linkage at chromosomes 11 and 14, are
and , respec-2.88 0.05p 2.83 3.23 1.84p 1.39
tively.
2. LOD scores under the heterogeneity model were
always less than or equal to the LOD scores under the
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Table 2
Summary of Conditional Linkage Analyses of 266 Families
REGION AND
CONDITIONAL MARKER
REGION AND
MARKER DETECTED
MLS
EMPIRICAL
P VALUEaPrimary Conditional
1p32 at D1S2134 5q31 at D5S1480 .98 3.21 .0002
15q13 at D15S153 .33 2.06 .0016
11q21 at D11s2002 8p23 at D8S1130 .87 2.90 !.0002
12q22 at D12S2070 1.13 2.00 .04
14q32 at D14S749 12q22 at D12S2070 1.13 2.15 .02
15q13 at D15S153 .33 2.70 !.0002
a For conditional analyses, determined from simulations of 5,000 replicates. Conditional
analysis was performed for 6p21, but no regions with increased evidence for linkage were
detected.
multiplicative model, similar to the results found in the
conditional analysis, in which significant linkage results
were observed only under a multiplicative model.
3. The two-locus LOD score under the general model
for markers D11S2002 andD12S2070 (LOD score 2.88)
was higher than the LOD score under either the heter-
ogeneity or the multiplicative model (LOD score 0.94
or 0.98, respectively). This may reflect a complex inter-
action between genes in these two regions, as could be
expected to occur for common diseases, such as asthma,
which are likely to have more than two genes—in ad-
dition to environmental factors—involved in control of
susceptibility. The interaction of the two trait genes may
differ among families and across populations, especially
if the background effects of other genes and environ-
mental factors vary.
Discussion
Genomewide screens for complex disorders often fail to
identify chromosomal regions with evidence for linkage
compelling enough to justify follow-up studies. The ge-
nomewide screen in our 266 families from three ethnic
populations provided preliminary evidence for linkage
at 14q32, 5q31, and 12q22, with LOD scores of 1–2
(figure 1). Genomewide analysis was performed sepa-
rately for each of the three ethnic groups, and the strong-
est evidence for linkage was seen at 6p21 in European
Americans, at 11q21 in African Americans, and at 1p32
in Hispanics. These results appear to reflect an inherent
mismatch between the genetic complexity of these traits
and the rather simplistic genetic analyses usually per-
formed for primary linkage studies. Although we rou-
tinely characterize complex disorders as arising from the
actions and interactions of many genetic and nongenetic
factors, primary analyses generally do not consider the
effects from multiple susceptibility factors simulta-
neously. When multiple loci contribute simultaneously
to a trait but only a single susceptibility locus is consid-
ered in analysis, the magnitude of the loss of power to
detect linkage depends on the underlying genetic model
(Knapp et al. 1994). There are, however, clear examples,
in animal studies, of loci showing little or no major
effects in a primary analysis but, nevertheless, contrib-
uting substantially to the genetics of the trait, when an-
alyzed for gene-gene and/or gene-environment interac-
tions (Leiter et al. 1998; Clark 2000; Kuida and Beier
2000).
Results of our primary analysis of the complete CSGA
sample is, perhaps, typical of results of genome screens
for complex disorders. Although some chromosomal
regions reported in previous studies of asthma also pro-
vided nominally significant results in the present study
(e.g., 12q, 5q, 11q) (Marsh et al. 1994; Barnes et al.
1996; Daniels et al. 1996; Doull et al. 1996; Ober et
al. 1998; Bleecker et al. 1999; Wjst et al. 1999), these
were not the regions with the highest LOD scores in
the current genomewide analyses. Moreover, only a sub-
set of the regions showing the strongest evidence for
linkage in the preliminary CSGA (1997) data showed
a comparable effect in the total CSGA sample. The dif-
ferences in magnitude of the LOD scores were due to
both the addition of new families and the expansion of
a portion of the original families to include additional
relatives. The challenge is now to prioritize regions for
follow-up fine-mapping studies—and to optimize gene
identification, by the development of testable models
for interactions between chromosomal regions likely to
contain asthma-susceptibility loci.
We have utilized the results from the conditional and
two-locus analyses to develop a model for gene-gene
interaction. Three observations from the results of the
conditional analyses are noteworthy. First, increased
evidence for linkage at several regions was repeatedly
observed when a positive relationship between the two
loci was assumed (table 2). For example, conditional
analyses based on evidence of linkage at either 11q21
or 14q32 resulted in significantly increased evidence of
linkage at 12q22; the analyses conditional on linkage
at either 1p32 or 14q32 resulted in significantly in-
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Table 3
Summary of Two-Locus IBD Models Using Affected Sib Pairs from 266 Families
MARKERS
(LOCUS 1/LOCUS 2)
LOD SCORE (EMPIRICAL P VALUEa)
Single-Locus Two-Locus
Locus 1 Locus 2 Heterogeneity Multiplicative General
D1S2134/D5S1480 1.24 (.02) .53 (.08) 1.67 (.02) 1.77 (.01) 2.11 (.01)
D1S2134/D15S153 1.24 (.02) .05 (.40) 1.26 (.04) 1.29 (.04) 1.68 (.03)
D11S2002/D8S1130 .05 (.40) .28 (.17) .33 (.31) .33 (.31) .34 (.37)
D11S2002/D12S2070 .05 (.40) .93 (.03) .94 (.08) .98 (.07) 2.88 (.003)
D14S749/D12S2070 1.84 (.004) .93 (.03) 2.59 (.003) 2.73 (.001) 3.23 (.001)
D14S749/D15S153 1.84 (.004) .05 (.40) 1.87 (.01) 1.89 (.01) 1.98 (.01)
a Determined from simulation of 5,000 replicates.
Table 4
Summary of Evidence for Linkage to Chromosomes 1, 5, 11, 12,
and 14
MARKERS
(LOCUS 1/LOCUS 2)
LOD SCORES (EMPIRICAL P VALUE)
Single Locus
Two Locus ConditionalaLocus 1 Locus 2
D1S2134/D5S1480 1.24 .53 2.11 (.01) 3.21 (.0002)
D11S2002/D12S2070 .05 .93 2.88 (.003) 2.00 (.04)
D14S749/D12S2070 1.84 .93 3.23 (.001) 2.15 (.02)
a Summary of conditional analyses from table 2.
creased evidence for linkage at 15q13; and the analyses
conditional on linkage at either 1p32 or 11q21 resulted
in significantly increased evidence for linkage at 8p23.
Second, increased evidence for linkage at several regions
was observed in multiple ethnic groups. Although the
evidence for linkage at 5q31 was nominally significant
in the Hispanic population in the genomewide screen,
increased evidence for linkage (LOD score 3.21) at this
region was observed in all three populations after con-
ditioning on linkage at 1p32: the LOD scores increased
from 0.98 to 3.21 in the entire group and to 2.1, 1.33,
and 0.77 at 5q31 in Hispanics, African Americans,
and European Americans, respectively. Third, several
regions identified through use of conditional analyses
are consistent with those identified in previously pub-
lished studies. For asthma and related phenotypes, link-
age to 5q has been found in several different popula-
tions, including the Amish (Marsh et al. 1994), the
Dutch (Meyers et al. 1994; Postma et al. 1995), and
the Hutterites (Ober et al. 1998). Although originally
described for atopy only, linkage to 11q was one of the
first linkages reported for atopy or asthma (Cookson et
al. 1989). Evidence for linkage at 12q has also been
observed in several studies (Barnes et al. 1996; Ober et
al. 1998; Wjst et al. 1999). Many of these reported
regions are broad, and it is not clear whether there may
be multiple susceptibility genes or whether different
genes may be detected in different studies.
Affected-sib-pair two-locus analysis, an independent
analytical approach complementing conditional analy-
sis, provides further evidence of linkage in several of
the regions seen in the conditional analyses (table 4).
For example, the estimated joint IBD sharing at 12q22
and 14q32 and at 12q22 and 11q21 were both signif-
icantly higher than expected among affected sib pairs,
similar to the results at 12q22 after conditioning on
linkage at either 14q32 or 11q21. The joint IBD sharing
at 1p34 and 5q31 was significantly higher than expected
among affected sib pairs, similar to the results seen for
5q31 after conditioning on linkage at 1p32. It is worth
noting that, because of computational limitations, nom-
inal P values, which do not consider multiple tests, were
reported in the two-locus analyses. Caution should be
used in interpreting the level of significance.
By the nature of the analyses, subsets of pedigrees are
used in the conditional analysis, whereas the complete
set of pedigrees is used in the two-locus analysis. The
pros and cons of the use of a subset versus use of the
complete set of families are dependent on the true ge-
netic mechanisms, which remain unknown. However,
it is encouraging that similar results were obtained from
the two different analytical approaches.
On the basis of the results both of the primary linkage
studies in the complete CSGA sample and of subsequent
conditional and two-locus analyses, we suggest a model
(fig. 3) summarizing the chromosomal regions with ev-
idence for linkage and the possible gene-gene interac-
tion. This model should be tested further, either through
primary linkage analysis or through conditional or two-
locus analysis of different data sets (Goring et al. 2000).
This model may be useful in the setting of priorities for
follow-up studies, as well as for the narrowing of
regions in fine-mapping studies. For example, the rel-
atively modest LOD score for the 14q region, as well
as this region’s novel location, would have given it un-
certain priority for follow-up studies. However, two dif-
ferent regions showed significantly increased evidence
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Figure 3 Summary of conditional analysis of 266 CSGA families: conditional on chromosome 11q21, a positive relationship was observed
with loci on 12q22 and 8p23; conditional on 14q32, a positive relationship was observed for 12q22 and 15q13; and, conditional on 1p32, a
positive relationship was observed for 8p23, 15q13, and 5q31.
for linkage conditional on evidence for linkage at
14q32, and each of those regions was independently
identified in analyses with other loci. This increases the
likelihood that 14q32 contains an asthma-susceptibility
locus. Although it is not simple to assess the overall
significance of the conditional and two-locus analyses,
both the consistency of these results across chromoso-
mal regions in our different study populations and their
consistency with previously reported asthma linkage
studies reinforce the likelihood that these regions con-
tain asthma-susceptibility loci.
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